Previous close | 0.1300 |
Open | 0.1300 |
Bid | 0.1200 |
Ask | 0.1900 |
Strike | 100.00 |
Expiry date | 2023-05-19 |
Day's range | 0.1300 - 0.1300 |
Contract range | N/A |
Volume | |
Open interest | N/A |
Zacks.com users have recently been watching AbbVie (ABBV) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
AbbVie (NYSE: ABBV) today announced it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration (FDA) for the New Drug Application (NDA) for ABBV-951 (foscarbidopa/foslevodopa) for the treatment of motor fluctuations in adults with advanced Parkinson's disease.
In the latest trading session, AbbVie (ABBV) closed at $156.12, marking a +1.23% move from the previous day.